CD163 and neoplasm: The type and spatial distribution of the immune infiltrate in EOC was assessed by IHC upon staining for CD3, CD20 and CD163 on the whole cohort, and by flow cytometry by CD3, CD19 and CD33 on 19 freshly processed tumor samples.